C. Schürfeld

Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases.

K. Stark, A. Ekici, Markus Gödel, 2022, Kidney international.

Case report-Rapid regression of xanthomas under lipoprotein apheresis in a boy with homozygous familial hypercholesterolemia.

W. März, U. Laufs, J. Katzmann, 2018, Journal of clinical lipidology.

Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity

L. Weber, Joenna Driemeyer, J. König, 2018, Pediatric Nephrology.

Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis.

L. Weber, Joenna Driemeyer, J. König, 2020, The American journal of cardiology.

ALL-Trans Retinoic Acid (ATRA) in the Treatment of Myelodysplastic Syndromes: Results in 5 Cases

C. Schürfeld, H. Brass, M. Möller, 1994 .

Maternally inherited diabetes and deafness (MIDD): unusual occult exocrine pancreatic manifestation in an affected German family.

J. Riemann, T. Schleiffer, C. Schürfeld, 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Real‐world study: Escalating targeted lipid‐lowering treatment with PCSK9‐inhibitors and lipoprotein apheresis

A. Raabe, W. Bernhardt, M. Ketteler, 2019, Journal of clinical apheresis.